These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2453712)

  • 1. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
    Nikiforova TV; Kuznetsova NN; Vavilova LM
    Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK; Williams DG
    Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
    [No Abstract]   [Full Text] [Related]  

  • 4. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemistry and function of the complement system.
    Müller-Eberhard HJ
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 8. C1, C4, and C2 components of the classical pathway of complement and regulatory proteins.
    Gigli I; Tausk FA
    Methods Enzymol; 1988; 162():626-39. PubMed ID: 3226327
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for activation of the alternate pathway in glomerulonephritis.
    Michael AF; McLean RH
    Adv Nephrol Necker Hosp; 1974; 4():49-66. PubMed ID: 4219999
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated bactericidal system: evidence for a new pathway of complement action.
    Moreau SC; Skarnes RC
    Science; 1975 Oct; 190(4211):278-80. PubMed ID: 1101380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the early components of the classical complement pathway under physiologic conditions.
    Ziccardi RJ
    J Immunol; 1981 May; 126(5):1769-73. PubMed ID: 7217665
    [No Abstract]   [Full Text] [Related]  

  • 13. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a: a mediator of chemotaxis and cellular release reactions.
    Gerard C; Hugli TE
    Kroc Found Ser; 1981; 14():147-60. PubMed ID: 6975805
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
    Hong K; Kinoshita T; Inoue K
    J Immunol; 1981 Jul; 127(1):109-14. PubMed ID: 6909271
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of complement consumption by atopic allergens.
    Berrens L; Van Rijswijk-Verbeek J; Guikers CL
    Immunochemistry; 1976 May; 13(5):367-72. PubMed ID: 939579
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
    Ballow M; Fang F; Good RA; Day NK
    Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.